232 related articles for article (PubMed ID: 6266257)
1. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
Weisbrode SE
Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
[TBL] [Abstract][Full Text] [Related]
2. The effects of the major vitamin D metabolites upon the resolution of osteomalacia in uremic adult rats.
Lieuallen WG; Weisbrode SE; Horst RL
Bone; 1990; 11(4):267-73. PubMed ID: 2242292
[TBL] [Abstract][Full Text] [Related]
3. Morphometric analysis of skeletal response to vitamin D in uremic rats fed a low calcium diet.
Weisbrode SE; Capen CC
Virchows Arch B Cell Pathol Incl Mol Pathol; 1979 Jun; 30(3):275-80. PubMed ID: 43007
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
7. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
Lieuallen WG; Weisbrode SE
J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats.
Vukicević S; Krempien B; Stavljenić A
J Bone Miner Res; 1987 Dec; 2(6):533-45. PubMed ID: 3502683
[TBL] [Abstract][Full Text] [Related]
9. Modulation of renal production of 24,25- and 1,25-dihydroxyvitamin D3 in young and adult rats by dietary calcium, phosphorus, and 1,25-dihydroxyvitamin D3.
Armbrecht HJ; Zenser TV; Davis BB
Endocrinology; 1982 Jun; 110(6):1983-8. PubMed ID: 6978809
[TBL] [Abstract][Full Text] [Related]
10. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
11. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.
Fournier A; Morinière PH; Oprisiu R; Yverneau-Hardy P; Westeel PF; Mazouz H; el Esper N; Ghazali A; Boudailliez B
Nephron; 1995; 71(3):254-83. PubMed ID: 8569975
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
von Herrath D; Kraft D; Schaefer K; Krempien B
MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
[No Abstract] [Full Text] [Related]
13. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
Marie PJ; Travers R; Glorieux FH
Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
[TBL] [Abstract][Full Text] [Related]
14. Effects of serum calcium and phosphorus on skeletal mineralization in vitamin D-deficient rats.
Holtrop ME; Cox KA; Carnes DL; Holick MF
Am J Physiol; 1986 Aug; 251(2 Pt 1):E234-40. PubMed ID: 3740259
[TBL] [Abstract][Full Text] [Related]
15. The effects of uremia and dietary phosphorus on the bone of rats.
Lieuallen WG; Weisbrode SE; Horst RL; Nagode LA
Bone; 1990; 11(1):41-6. PubMed ID: 2331430
[TBL] [Abstract][Full Text] [Related]
16. High-phosphorus diet maximizes and low-dose calcitriol attenuates skeletal muscle changes in long-term uremic rats.
Acevedo LM; López I; Peralta-Ramírez A; Pineda C; Chamizo VE; Rodríguez M; Aguilera-Tejero E; Rivero JL
J Appl Physiol (1985); 2016 May; 120(9):1059-69. PubMed ID: 26869708
[TBL] [Abstract][Full Text] [Related]
17. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF
J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
Boyce RW; Weisbrode SE
Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats fed a low-calcium diet.
Weisbrode SE; Capen CC; Norman AW
Am J Pathol; 1978 Aug; 92(2):459-72. PubMed ID: 677270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
